Molecular Devices has been a life sciences industry leader for 40 years. We believe in the revolutionary promise of 3D cell models to advance next generation drug discovery. Whether you’re making the transition from 2D to 3D cell culture for the first time, scaling your organoid development program, or integrating a fully-automated screening workflow, we’re here to help.
Our robust portfolio of end-to-end high-throughput solutions, user-friendly AI-powered data analysis, and committed 3D biotechnology investments, will support you in overcoming all your 3D biology challenges. Our solutions include:
- An AI-driven automated cell culture solution
-Customized organoid expansion services
-Automated 3D bioprinting platforms
-High-content, high-throughput confocal imaging and screening solutions
-Ai-powered data analysis software
-Fully-integrated, end-to-end automated high-throughput screening platforms.
